z-logo
HomeZAIABlog
open-access-imgOpen Access
Impact of relative dose intensity in gemcitabine–cisplatin chemotherapy for metastatic urothelial carcinoma
Author(s) -
Naoki Kohei,
Kyohei Sugiyama,
Ichiro Chihara,
Yusuke Muro,
Masaaki Imamura,
Yasunori Nishio,
Koji Yoshimura
Publication year - 2018
Publication title -
sage open medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.125
0
ISSN - 2050-3121
DOI - 10.1177/2050312118783011
Subject(s) - gemcitabine , medicine , cisplatin , chemotherapy , regimen , oncology , chemotherapy regimen , urology
Individual low relative dose intensity management in the first-line gemcitabine-cisplatin chemotherapy may be an acceptable option for patients with metastatic urothelial carcinoma.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom

About

AboutCareersPublisher PartnersContact UsGet Organisational Trial or Quote

Learn

FAQsBlogTerms of UsePrivacy Policy

Download the Zendy App

Get it on
Google Play
Download on the
App Store

Discover

Explore

Copyright Knowledge E © 2025. All Rights Reserved.